SRCIN1 and breast cancer: A first immunohistochemical analysis with specific monoclonal antibodies on a small cohort of human breast cancers revealed that p140Cap is lost in the most aggressive and highly proliferative cancers, suggesting an inverse correlation between its expression and the state of malignancy (Damiano et al., 2010).